CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: Further study of the function of CD8+ TRM cells from the BM of DN-CML patients and looking for the BM microenvironment mechanisms which lead to this result may help to understand more immune dysfunction mechanisms during the development of CML.